Palbociclib After CDK and Endocrine Therapy (PACE)
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Palbociclib|DRUG: Fulvestrant|DRUG: Avelumab
Sponsor: Dana-Farber Cancer Institute
Collaborators: Pfizer